HK Inno.N Corp Intrinsic Valuation and Fundamental Analysis - HK Inno.N Corp - Alpha Spread
H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 50 400 KRW -0.2% Market Closed
Market Cap: 1.4T KRW
Have any thoughts about
HK Inno.N Corp?
Write Note

Intrinsic Value

The intrinsic value of one HK Inno.N Corp stock under the Base Case scenario is 69 001.04 KRW. Compared to the current market price of 50 400 KRW, HK Inno.N Corp is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
69 001.04 KRW
Undervaluation 27%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
HK Inno.N Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HK Inno.N Corp cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HK Inno.N Corp?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about HK Inno.N Corp

Provide an overview of the primary business activities
of HK Inno.N Corp.

What unique competitive advantages
does HK Inno.N Corp hold over its rivals?

What risks and challenges
does HK Inno.N Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for HK Inno.N Corp.

Provide P/S
for HK Inno.N Corp.

Provide P/E
for HK Inno.N Corp.

Provide P/OCF
for HK Inno.N Corp.

Provide P/FCFE
for HK Inno.N Corp.

Provide P/B
for HK Inno.N Corp.

Provide EV/S
for HK Inno.N Corp.

Provide EV/GP
for HK Inno.N Corp.

Provide EV/EBITDA
for HK Inno.N Corp.

Provide EV/EBIT
for HK Inno.N Corp.

Provide EV/OCF
for HK Inno.N Corp.

Provide EV/FCFF
for HK Inno.N Corp.

Provide EV/IC
for HK Inno.N Corp.

Show me price targets
for HK Inno.N Corp made by professional analysts.

What are the Revenue projections
for HK Inno.N Corp?

How accurate were the past Revenue estimates
for HK Inno.N Corp?

What are the Net Income projections
for HK Inno.N Corp?

How accurate were the past Net Income estimates
for HK Inno.N Corp?

What are the EPS projections
for HK Inno.N Corp?

How accurate were the past EPS estimates
for HK Inno.N Corp?

What are the EBIT projections
for HK Inno.N Corp?

How accurate were the past EBIT estimates
for HK Inno.N Corp?

Compare the revenue forecasts
for HK Inno.N Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of HK Inno.N Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of HK Inno.N Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of HK Inno.N Corp compared to its peers.

Compare the P/E ratios
of HK Inno.N Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing HK Inno.N Corp with its peers.

Analyze the financial leverage
of HK Inno.N Corp compared to its main competitors.

Show all profitability ratios
for HK Inno.N Corp.

Provide ROE
for HK Inno.N Corp.

Provide ROA
for HK Inno.N Corp.

Provide ROIC
for HK Inno.N Corp.

Provide ROCE
for HK Inno.N Corp.

Provide Gross Margin
for HK Inno.N Corp.

Provide Operating Margin
for HK Inno.N Corp.

Provide Net Margin
for HK Inno.N Corp.

Provide FCF Margin
for HK Inno.N Corp.

Show all solvency ratios
for HK Inno.N Corp.

Provide D/E Ratio
for HK Inno.N Corp.

Provide D/A Ratio
for HK Inno.N Corp.

Provide Interest Coverage Ratio
for HK Inno.N Corp.

Provide Altman Z-Score Ratio
for HK Inno.N Corp.

Provide Quick Ratio
for HK Inno.N Corp.

Provide Current Ratio
for HK Inno.N Corp.

Provide Cash Ratio
for HK Inno.N Corp.

What is the historical Revenue growth
over the last 5 years for HK Inno.N Corp?

What is the historical Net Income growth
over the last 5 years for HK Inno.N Corp?

What is the current Free Cash Flow
of HK Inno.N Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for HK Inno.N Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
HK Inno.N Corp

Current Assets 402.7B
Cash & Short-Term Investments 86.9B
Receivables 144.3B
Other Current Assets 171.5B
Non-Current Assets 1.4T
Long-Term Investments 25.5B
PP&E 308.4B
Intangibles 1.1T
Other Non-Current Assets 12.4B
Current Liabilities 568.2B
Accounts Payable 80.3B
Accrued Liabilities 43.1B
Short-Term Debt 210B
Other Current Liabilities 234.8B
Non-Current Liabilities 48.7B
Long-Term Debt 36.6B
Other Non-Current Liabilities 12B
Efficiency

Earnings Waterfall
HK Inno.N Corp

Revenue
856.6B KRW
Cost of Revenue
-456.1B KRW
Gross Profit
400.6B KRW
Operating Expenses
-323B KRW
Operating Income
77.5B KRW
Other Expenses
-22.8B KRW
Net Income
54.7B KRW

Free Cash Flow Analysis
HK Inno.N Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

HK Inno.N Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive Free Cash Flow
50/100
Profitability
Score

HK Inno.N Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

HK Inno.N Corp's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
45/100
Solvency
Score

HK Inno.N Corp's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
HK Inno.N Corp

Wall Street analysts forecast HK Inno.N Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HK Inno.N Corp is 57 545 KRW with a low forecast of 50 500 KRW and a high forecast of 73 500 KRW.

Lowest
Price Target
50 500 KRW
0% Upside
Average
Price Target
57 545 KRW
14% Upside
Highest
Price Target
73 500 KRW
46% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HK Inno.N Corp?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Oct 7, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Want to learn more about HK Inno.N Corp dividends?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for HK Inno.N Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

HK Inno.N Corp

Country

Korea

Industry

Pharmaceuticals

Market Cap

1.4T KRW

Dividend Yield

0.69%

Description

HK inno.N Corp. engages in the provision of healthcare services. The company is headquartered in Chungju, Chungcheongbuk-Do. The company went IPO on 2021-08-09. The firm operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The firm sells its products within domestic market and to overseas markets.

Contact

CHUNGCHEONGBUK-DO
CHUNGJU
Osong Factory, 239, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu
+82264770000
www.inno-n.com

IPO

2021-08-09

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one HK Inno.N Corp stock?

The intrinsic value of one HK Inno.N Corp stock under the Base Case scenario is 69 001.04 KRW.

Is HK Inno.N Corp stock undervalued or overvalued?

Compared to the current market price of 50 400 KRW, HK Inno.N Corp is Undervalued by 27%.

Back to Top